SCHEMBL29396393

SCHEMBL29396393

CC(C)(C)c1cc(N)n(-c2ccccn2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.47
MAPK14 Q16539 3/20 0.46
FLT3 P36888 6/20 0.43
MAP4K4 O95819 2/20 0.43
PIM1 P11309 2/20 0.43
PRKACA P17612 2/20 0.43
CLK2 P49760 2/20 0.43
CDK5 Q00535 2/20 0.43
MAP4K2 Q12851 2/20 0.43
ROCK1 Q13464 2/20 0.43
DYRK1A Q13627 2/20 0.43
AURKB Q96GD4 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
PLK4 O00444 1/20 0.43
ROCK2 O75116 1/20 0.43
RPS6KA5 O75582 1/20 0.43
INSR P06213 1/20 0.43
ROS1 P08922 1/20 0.43
PHKG2 P15735 1/20 0.43
RPS6KB1 P23443 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013458 1.00 MAPT (0.47) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL6343666 0.84 KDM4E (0.50) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL16768793 0.81 MAPK14 (0.49) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL4077901 0.81 MAPK14 (0.52) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL12759919 0.81 MAPK14 (0.46) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL298130 0.81 MAPK14 (0.44) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL29395908 0.80 KDM4E (0.42) MAPK14MAPK13MAPK12MAPK11CDK8
SCHEMBL20627781 0.79 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11JAK2
SCHEMBL6343068 0.79 CYP1A2 (0.59) MAPTMAPK14FLT3MAP4K4PIM1
SCHEMBL2788198 0.79 GRN (0.51) MAPTMAPK14FLT3MAP4K4PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999057-A1 POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES ANAGENESIS BIOTECHNOLOGIES SAS (FR) 2022-05-25 EP disclosed
CN-114144410-A Polyarylurea derivatives and their use in the treatment of muscular diseases 阿纳格纳斯生物技术股份有限公司 2022-03-04 CN disclosed